174 related articles for article (PubMed ID: 29970717)
1. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
2. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
3. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
4. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians.
Wang W; Qin H; Zhou L; Ma J
J Cancer Res Ther; 2016; 12(2):676-80. PubMed ID: 27461631
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
Chen B; Cao L; Yang P; Zhou Y; Wu XT
Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
[TBL] [Abstract][Full Text] [Related]
8. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
9. MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis.
Qiu D; Han F; Zhuang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S490-S493. PubMed ID: 29970712
[TBL] [Abstract][Full Text] [Related]
10. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract][Full Text] [Related]
11. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
15. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis.
Zhang C; Ye Z; Zhang Z; Zheng J; Tang Y; Hou E; Huang Z; Meng L
Gene; 2020 Apr; 735():144365. PubMed ID: 31935498
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HLA-DP gene polymorphisms and the risk of hepatocellular carcinoma: a meta-analysis.
Zhang X; Zheng C; Zhou ZH; Li M; Gao YT; Jin SG; Sun XH; Gao YQ
Genet Mol Res; 2015 Dec; 14(4):15553-63. PubMed ID: 26634522
[TBL] [Abstract][Full Text] [Related]
19. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
20. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
